JENNIFER STEWART: Open Payments
NPI 1336994128 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 54 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $720 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 13 | $259 |
| AstraZeneca Pharmaceuticals LP | 11 | $217 |
| Novartis Pharmaceuticals Corporation | 11 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| AtriCure, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $37 |
| Endologix LLC | 1 | $27 |
| Itamar Medical Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: Assure WCD, LEQVIO, FARXIGA, Kerendia, VERQUVO, SYNERGY ABLATION SYSTEM, ELIQUIS, Torus Stent Graft System.
Industry payments across LA — which companies pay providers there.
